High-throughput screening

AI Revolutionizing Drug Discovery and Precision Medicine, Report Reveals

Artificial intelligence is fundamentally reshaping biotechnology and pharmaceutical research, according to a comprehensive industry analysis. The integration of machine learning and deep learning techniques is reportedly accelerating drug discovery while reducing development costs and timelines. Researchers suggest these advancements are paving the way for more personalized medical treatments and improved patient outcomes.

AI’s Transformative Impact on Drug Discovery

Artificial intelligence is revolutionizing pharmaceutical research and development, according to recent analysis in npj Digital Medicine. Sources indicate that AI applications in biotechnology are accelerating drug discovery processes that traditionally relied on labor-intensive techniques and trial-and-error experimentation. The report states that machine learning and natural language processing can analyze vast datasets more efficiently than conventional methods, significantly reducing development timelines.

by Michael TurnerOctober 20, 2025

Assistive Technology Earth Sciences

Nanobody-Guided ANGEL Technique Enables Efficient Endogenous Protein Fluorescent Labeling

Researchers have developed ANGEL, a breakthrough nanobody-guided approach for efficient fluorescent labeling of endogenous proteins. This innovative technique enables real-time visualization of protein dynamics under native regulatory conditions.

In a significant advancement for molecular biology and cellular imaging, researchers have developed a nanobody-guided approach that enables efficient fluorescent labeling of endogenous proteins. This breakthrough technique, termed ALFA Nanobody-guided Endogenous Labeling (ANGEL), addresses long-standing challenges in visualizing and screening small peptide knockins without fluorescence interference.